A critical review of controlled clinical trials for peripheral neuropathic pain and complex regional pain syndromes
- PMID: 9415498
- DOI: 10.1016/S0304-3959(97)00049-3
A critical review of controlled clinical trials for peripheral neuropathic pain and complex regional pain syndromes
Abstract
The purpose of this review was to identify and analyze the controlled clinical trial data for peripheral neuropathic pain (PNP) and complex regional pain syndromes (CRPS). A total of 72 articles were found, which included 92 controlled drug trials using 48 different treatments. The methods of these studies were critically reviewed and the results summarized and compared. The PNP trial literature gave consistent support (two or more trials) for the analgesic effectiveness of tricyclic antidepressants, intravenous and topical lidocaine, intravenous ketamine, carbamazepine and topical aspirin. There was limited support (one trial) for the analgesic effectiveness of oral, topical and epidural clonidine and for subcutaneous ketamine. The trial data were contradictory for mexiletine, phenytoin, topical capsaicin, oral non-steroidal anti-inflammatory medication, and intravenous morphine. Analysis of the trial methods indicated that mexiletine and intravenous morphine were probably effective analgesics for PNP, while non-steroidals were probably ineffective. Codeine, magnesium chloride, propranolol, lorazepam, and intravenous phentolamine all failed to provide analgesia in single trials. There were no long-term data supporting the analgesic effectiveness of any drug and the etiology of the neuropathy did not predict treatment outcome. Review of the controlled trial literature for CRPS identified several potential problems with current clinical practices. The trial data only gave consistent support for analgesia with corticosteroids, which had long-term effectiveness. There was limited support for the analgesic effectiveness of topical dimethylsulfoxyde (DMSO), epidural clonidine and intravenous regional blocks (IVRBs) with bretylium and ketanserin. The trial data were contradictory for intranasal calcitonin and intravenous phentolamine and analysis of the trial methods indicated that both treatments were probably ineffective for most patients. There were consistent trial data indicating that guanethidine and reserpine IVRBs were ineffective, and limited trial data indicating that droperidol and atropine IVRBs were ineffective. No placebo controlled data were available to evaluated sympathetic ganglion blocks (SGBs) with local anesthetics, surgical sympathectomy, or physical therapy. Only the capsaicin trials presented data which allowed for meta-analysis. This meta-analysis demonstrated a significant capsaicin effect with a pooled odds ratio of 2.35 (95% confidence intervals 1.48, 3.22). The methods scores were higher (P < 0.01) for the PNP trials (66.2 +/- 1.5, n = 66) than the CRPS trials (57.6 +/- 2.9, n = 26). The CRPS trials tended to use less subjects and were less likely to use placebo controls, double-blinding, or perform statistical tests for differences in outcome measures between groups. There was almost no overlap in the controlled trial literature between treatments for PNP and CRPS, and treatments used in both conditions (intravenous phentolamine and epidural clonidine) had similar results.
Comment in
-
Comments on Kingery, PAIN, 73 (1997) 123-139. Controlled randomized trials failed to demonstrate that sympathetic blocks (SB) are more effective than placebo for relieving complex regional pain syndromes (CRPS).Pain. 1999 Feb;79(2-3):317-9. doi: 10.1016/s0304-3959(98)00173-0. Pain. 1999. PMID: 10068178 No abstract available.
Similar articles
-
Analgesic therapy in postherpetic neuralgia: a quantitative systematic review.PLoS Med. 2005 Jul;2(7):e164. doi: 10.1371/journal.pmed.0020164. Epub 2005 Jul 26. PLoS Med. 2005. PMID: 16013891 Free PMC article. Review.
-
A Novel Compound Analgesic Cream (Ketamine, Pentoxifylline, Clonidine, DMSO) for Complex Regional Pain Syndrome Patients.Pain Pract. 2016 Jan;16(1):E14-20. doi: 10.1111/papr.12404. Epub 2015 Nov 7. Pain Pract. 2016. PMID: 26547813
-
Complex regional pain syndrome: which treatments show promise?J Fam Pract. 2005 Jul;54(7):599-603. J Fam Pract. 2005. PMID: 16009087 Review.
-
Systemic administration of local anesthetic agents to relieve neuropathic pain.Cochrane Database Syst Rev. 2019 Oct 7;2019(10). doi: 10.1002/14651858.CD003345.pub2. Cochrane Database Syst Rev. 2019. PMID: 31684682
-
Rational pain management in complex regional pain syndrome 1 (CRPS 1)--a network meta-analysis.Pain Med. 2014 Sep;15(9):1575-89. doi: 10.1111/pme.12466. Pain Med. 2014. PMID: 25234478
Cited by
-
The complex regional pain syndrome: Diagnosis and management strategies.Neurosciences (Riyadh). 2023 Oct;28(4):211-219. doi: 10.17712/nsj.2023.4.20230034. Neurosciences (Riyadh). 2023. PMID: 37844940 Free PMC article. Review.
-
Prescription Trends in Complex Regional Pain Syndrome: A Retrospective Case-Control Study.Brain Sci. 2023 Jun 30;13(7):1012. doi: 10.3390/brainsci13071012. Brain Sci. 2023. PMID: 37508943 Free PMC article.
-
Algorithm for multimodal medication therapy in patients with complex regional pain syndrome.J Yeungnam Med Sci. 2023 Nov;40(Suppl):S125-S128. doi: 10.12701/jyms.2023.00360. Epub 2023 Jul 12. J Yeungnam Med Sci. 2023. PMID: 37434359 Free PMC article.
-
Pharmacologic Treatments in Upper Extremity Complex Regional Pain Syndrome: A Review and Analysis of Quality of Evidence.Hand (N Y). 2024 Jun;19(4):533-544. doi: 10.1177/15589447221131847. Epub 2022 Nov 24. Hand (N Y). 2024. PMID: 36424817 Review.
-
The role of topical capsaicin gel in pain management during microfocused ultrasound treatment for neck laxity.Skin Res Technol. 2023 Jan;29(1):e13240. doi: 10.1111/srt.13240. Epub 2022 Nov 16. Skin Res Technol. 2023. PMID: 36382669 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous